Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Respiratory Medicine

Journal Scan / Research · December 19, 2022

Incidence of Viral Rebound After Treatment With Nirmatrelvir–Ritonavir and Molnupiravir

JAMA Network Open


Additional Info

JAMA Network Open
Incidence of Viral Rebound After Treatment With Nirmatrelvir-Ritonavir and Molnupiravir
JAMA Netw Open 2022 Dec 01;5(12)e2245086, GL Wong, TC Yip, MS Lai, VW Wong, DS Hui, GC Lui

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading